Metabolic health
Metabolic & Weight Management
The GLP-1 and GLP-1/GIP receptor agonists behind much of modern metabolic and weight-management medicine.
Commonly discussed
semaglutide, tirzepatide (GLP-1 / GIP)
The GLP-1 and GLP-1/GIP receptor agonists behind much of modern metabolic and weight-management medicine.
Prescription therapies for weight & metabolic health
Why it matters
Sustainable energy for daily life is the goal behind metabolic-health research.
Lifestyle photography — general mood imagery, not a patient photo or a documented result.
— The science, plainly
What it is
Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GLP-1/GIP receptor agonist. Both mimic gut hormones that influence blood sugar, insulin release, appetite signaling, and the rate at which the stomach empties.
What research explores
These are among the most rigorously studied compounds in this space, with large randomized controlled trials supporting their approved uses in type-2 diabetes and chronic weight management under medical supervision.
Regulatory status
FDA-approved prescription medications (e.g. Ozempic/Wegovy, Mounjaro/Zepbound). Available for human use only by prescription, which is not what this site does. Any material listed here is supplied for research and laboratory use only.
This page is general educational background, not medical advice. Platinum peptides are supplied by Peptara Compounds for research and laboratory use only, including veterinary and animal-therapy research, and are not for human consumption. Statements here have not been evaluated by the FDA.